Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
San Gabriel Valley Index
San Gabriel Valley
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Bio-Rad Laboratories
(NY:
BIO
)
313.42
-1.52 (-0.48%)
Official Closing Price
Updated: 7:00 PM EDT, Aug 26, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Bio-Rad Laboratories
< Previous
1
2
3
4
5
6
Next >
Bio-Rad Reports First-Quarter 2022 Financial Results
April 28, 2022
From
Bio-Rad Laboratories, Inc.
Via
Business Wire
Bio-Rad to Report First-Quarter Financial Results, Thursday, April 28, 2022
April 18, 2022
From
Bio-Rad Laboratories, Inc.
Via
Business Wire
Will Investment Gains For Google Parent Reverse In Upcoming Earnings Report?
April 05, 2022
Investment gains have played a big role in earnings beats for GOOGL stock in recent years but that may reverse in its first-quarter earnings.
Via
Investor's Business Daily
Overview Of Value Stocks In The Healthcare Sector
March 28, 2022
What are Value Stocks? A value stock traditionally has a lower price when compared to stock prices of companies in the same industry. This indicates that the company may be...
Via
Benzinga
Earnings Scheduled For February 10, 2022
February 10, 2022
Companies Reporting Before The Bell • Canada Goose Hldgs (NYSE:GOOS) is projected to report quarterly earnings at $1.46 per share on revenue of $584.49 million.
Via
Benzinga
Upcoming Stock Splits 2022: 20 Companies That Could Follow Amazon’s Lead
March 10, 2022
We're taking a gander at more companies that could follow Amazon's (AMZN) lead with potential upcoming stock splits in 2022.
Via
InvestorPlace
Bio-Rad Presents Growth Strategy and Acceleration of Financial Targets at Investor Day
February 25, 2022
From
Bio-Rad Laboratories, Inc.
Via
Business Wire
7 Stocks To Buy at the Bottom After the Market Rout
February 17, 2022
The recent market rout offers an opportune entry point to these seven robust stocks. These are good stocks to buy at their bottom now.
Via
InvestorPlace
The Daily Biotech Pulse: Adcom Recommends Additional Trials For Lilly's Partnered Cancer Drug, Novavax Touts Pediatric Vaccine Data, TC Biopharm IPO
February 11, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Adcom Rules That Lilly May Have To Conduct Additional Studies For Co-...
Via
Benzinga
Recap: Bio-Rad Laboratories Q4 Earnings
February 10, 2022
Bio-Rad Laboratories (NYSE:BIO) reported its Q4 earnings results on Thursday, February 10, 2022 at 04:00 PM. Here's what investors need to know about the announcement.
Via
Benzinga
Bio-Rad Reports Fourth-Quarter and Full-Year 2021 Financial Results
February 10, 2022
From
Bio-Rad Laboratories, Inc.
Via
Business Wire
The Daily Biotech Pulse: AstraZeneca Q4 Gets COVID Boost, Seagen Plunges On Earnings, Adcom Test Awaits Lilly
February 10, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
Bio-Rad Laboratories's Earnings: A Preview
February 09, 2022
Bio-Rad Laboratories (NYSE:BIO) is set to give its latest quarterly earnings report on Thursday, 2022-02-10. Here's what investors need to know before the announcement. Analysts estimate that Bio-Rad...
Via
Benzinga
The Week Ahead In Biotech (Feb. 6-12): Pfizer, AstraZeneca Earnings, Conference Presentations, IPOs And More
February 06, 2022
Biotech stocks managed to close the week ending Feb. 4 with gains. Stocks recovered along with the broader markets early in the week, but came under pressure midweek amid negative reaction to some big...
Via
Benzinga
Bio-Rad to Host Investor Day on February 25
February 02, 2022
From
Bio-Rad Laboratories, Inc.
Via
Business Wire
Bio-Rad to Report Fourth-Quarter and Full-Year 2021 Financial Results, Thursday, February 10, 2022
January 25, 2022
From
Bio-Rad Laboratories, Inc.
Via
Business Wire
Overview Of Value Stocks In The Healthcare Sector
January 24, 2022
Understanding Value Stocks A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E...
Via
Benzinga
Bio-Rad to Participate in Fireside Chat During the 40th Annual J.P. Morgan Healthcare Conference on January 11
January 05, 2022
From
Bio-Rad Laboratories, Inc.
Via
Business Wire
Free COVID Tests: What Stocks Will Benefit?
December 23, 2021
The government hasn’t announced yet what company or companies it will be buying from, but there are several businesses involved in producing these kits.
Via
Talk Markets
Bio-Rad Appoints Simon May Executive Vice President and Life Science Group President
December 16, 2021
From
Bio-Rad Laboratories, Inc.
Via
Business Wire
A Look Into Healthcare Sector Value Stocks
November 01, 2021
Understanding Value Stocks A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E...
Via
Benzinga
The Daily Biotech Pulse: Gilead-Merck Collaborate For Breast Cancer Study, Decision Day For ANI Pharma, Pfizer Gets Canadian Regulatory Nod, 3 IPOs
October 29, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Gilead, Merck to Study Trodelvy-Keytruda Combo For Breast Cancer Gilead, Inc...
Via
Benzinga
Bio-Rad Laboratories, inc (BIO) Q3 2021 Earnings Call Transcript
October 28, 2021
BIO earnings call for the period ending September 30, 2021.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Bio-Rad Reports Third-Quarter 2021 Financial Results
October 28, 2021
From
Bio-Rad Laboratories, Inc.
Via
Business Wire
The Daily Biotech Pulse: Merck Reports Beat-And-Raise Quarter, Pfizer-BioNTech Snag Orders For Additional Vaccine Doses, HCW Cleared For Phase 1 Study Of Pancreatic Cancer Drug
October 28, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Corvus' China Partner Approved For Early Stage Study Of CPI-818 In...
Via
Benzinga
Thermo Fisher Stock Strength Rating Climbs To 81; Medical Devices Maker Shows Market Leadership
October 28, 2021
Thermo Fisher Scientific shows improving price performance, earning an upgrade to its IBD Relative Strength Rating from 77 to 81.
Via
Investor's Business Daily
Preview: Bio-Rad Laboratories's Earnings
October 27, 2021
Bio-Rad Laboratories (NYSE:BIO) is set to give its latest quarterly earnings report on Thursday, 2021-10-28. Here's what investors need to know before the announcement. Analysts...
Via
Benzinga
Overview Of Value Stocks In The Healthcare Sector
October 25, 2021
What Defines a Value Stock? A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E...
Via
Benzinga
Bio-Rad to Report Third-Quarter 2021 Financial Results, Thursday, October 28, 2021
October 15, 2021
From
Bio-Rad Laboratories, Inc.
Via
Business Wire
The Week Ahead In Biotech (Oct. 24-30): Eyenovia, ANI Pharma, Clearside Medical FDA Decisions, Merck, Bristol-Myers Squibb Earnings, IPOs And More
October 24, 2021
Biotech stocks posted gains for the second week running, supported by multiple catalysts that included a good start to the big pharma reporting season and broader market strength...
Via
Benzinga
Exposures
Product Safety
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.